BTLA/HVEM signaling: Milestones in research and role in chronic hepatitis B virus infection

101Citations
Citations of this article
93Readers
Mendeley users who have this article in their library.

Abstract

B- and T-lymphocyte attenuator (BTLA) is an immune-regulatory receptor, similar to CTLA-4 and PD-1, and is mainly expressed on B-, T-, and all mature lymphocyte cells. Herpes virus entry mediator (HVEM)-BTLA plays a critical role in immune tolerance and immune responses which are areas of intense research. However, the mechanisms of the BTLA and the BTLA/HVEM signaling pathway in human diseases remain unclear. This review describes the research milestones of BTLA and HVEM in chronological order and their role in chronic HBV infection.

Cite

CITATION STYLE

APA

Yu, X., Zheng, Y., Mao, R., Su, Z., & Zhang, J. (2019). BTLA/HVEM signaling: Milestones in research and role in chronic hepatitis B virus infection. Frontiers in Immunology. Frontiers Media S.A. https://doi.org/10.3389/fimmu.2019.00617

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free